PPHM
Peregrine Pharmaceuticals, Inc.
NasdaqCM
People also watch:OXGNCTICGALETHLDXOMA
0.37-0.00 (-0.94%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close0.37
Open0.37
Bid0.37 x 2900
Ask0.37 x 100
52wk Range0.29 - 1.33
Day's Range0.37 - 0.38
Volume542,375
Avg Vol (3m)1,586,479
As of 1:36 PM EDT. NasdaqCM Real Time Price. Market open.
  • Peregrine Pharmaceuticals, Inc. :PPHM-US: Earnings Analysis: 2016 By the Numbers : July 22, 2016
    Capital Cube5 days ago

    Peregrine Pharmaceuticals, Inc. :PPHM-US: Earnings Analysis: 2016 By the Numbers : July 22, 2016

    Click here to see latest analysisPeregrine Pharmaceuticals, Inc. reports financial results for the year ended April 30, 2016.HighlightsGross margins widened from 41.78% to 48.61% compared to the same period last year, operating (EBITDA) margins now -122.69% from -184.68%.Change in operating cash flow of -9.92% compared to same period last year is about the same as […] (Read more...) The post Peregrine Pharmaceuticals, Inc. :PPHM-US: Earnings Analysis: 2016 By the Numbers : July 22, 2016 appeared first on CapitalCube.

  • Capital Cube9 days ago

    ETF’s with exposure to Peregrine Pharmaceuticals, Inc. : July 18, 2016

    Click here to see latest analysis*Disclaimer : This is as of previous day’s closeETF’s with exposure to Peregrine Pharmaceuticals, Inc.Here are 5 ETF’s with the largest exposure to PPHM-US. Comparing the performance and risk of Peregrine Pharmaceuticals, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us […] (Read more...) The post ETF’s with exposure to Peregrine Pharmaceuticals, Inc. : July 18, 2016 appeared first on CapitalCube.